Rapid and Facile Microwave-Assisted Synthesis of Palladium Nanoparticles and Evaluation of Their Antioxidant Properties and Cytotoxic Effects Against Fibroblast-Like (HSkMC) and Human Lung Carcinoma (A549) Cell Lines
Overview
Authors
Affiliations
We report here a simple microwave irradiation method (850 W, 3 min) for the synthesis of palladium nanoparticles (Pd NPs) using ascorbic acid (as reducing agent) and sodium alginate (as stabilizer agent). The synthesized nanoparticles were characterized using transmission electron microscopy (TEM), energy dispersive X-ray (EDX), X-ray diffraction spectroscopy (XRD), UV-Visible spectroscopy, and Fourier transform infrared spectroscopy (FTIR) techniques. Antioxidant properties and cytotoxic effects of as-synthesized Pd NPs and Pd (II) acetate were also assessed. UV-Vis study showed the formation of Pd NPs with maximum absorption at 345 nm. From TEM analysis, it was observed that the Pd NPs had spherical shape with particle size distribution of 13-33 nm. Based on DPPH radical scavenging activity and reducing power assay, the antioxidant activities of Pd NPs were significantly higher than the Pd (II) acetate (p < 0.05). At the same concentration of 640 μg/mL, the scavenging activities were 32.9 ± 3.2% (Pd (II) acetate) and 27.2 ± 2.1% (Pd NPs). For A549 cells treated 48 h with Pd NPs, Pd (II) acetate, and cisplatin, the measured concentration necessary causing 50% cell death (IC) was 7.2 ± 1.7 μg/mL, 32.1 ± 2.1 μg/mL, and 206.2 ± 3.5 μg/mL, respectively. On HSkMC cells, the IC of the Pd NPs (320 μg/mL) was higher compared to Pd (II) acetate (228.7 ± 3.6 μg/mL), which confirmed lower cytotoxicity of the Pd NPs.
Firmanti M, Ha J Sci Rep. 2024; 14(1):20182.
PMID: 39215073 PMC: 11364640. DOI: 10.1038/s41598-024-71141-8.
Barani M, Mir A, Roostaee M, Sargazi G, Adeli-Sardou M Bioprocess Biosyst Eng. 2024; 47(11):1915-1928.
PMID: 39127828 DOI: 10.1007/s00449-024-03077-2.
Nudelman R, Zuarets S, Lev M, Gavriely S, Meshi L, Zucker I Nanoscale Adv. 2023; 5(22):6115-6122.
PMID: 37941943 PMC: 10628991. DOI: 10.1039/d3na00385j.
Inorganic Nanomaterials Used in Anti-Cancer Therapies:Further Developments.
Dlugosz O, Matyjasik W, Hodacka G, Szostak K, Matysik J, Krawczyk P Nanomaterials (Basel). 2023; 13(6).
PMID: 36986024 PMC: 10051539. DOI: 10.3390/nano13061130.
Adeli-Sardou M, Shakibaie M, Forootanfar H, Jabari-Morouei F, Riahi-Madvar S, Ghafari-Shahrbabaki S World J Microbiol Biotechnol. 2022; 38(12):246.
PMID: 36289108 DOI: 10.1007/s11274-022-03418-x.